| Hermes Torres Martinez Sr, | |
|
163 Calle Domingo Colon, Aibonito, PR 00705-3421 | |
| (787) 735-4847 | |
| Not Available |
| Full Name | Hermes Torres Martinez Sr |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 163 Calle Domingo Colon, Aibonito, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558535336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 16937 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hermes Torres Martinez Sr, 163 Calle Domingo Colon, Aibonito, PR 00705-3421 Ph: (787) 735-4847 | Hermes Torres Martinez Sr, 163 Calle Domingo Colon, Aibonito, PR 00705-3421 Ph: (787) 735-4847 |
News Archive
A multi-center team led by James Langabeer II, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) has published a first-of-its-kind study in the Journal of the American Heart Association (JAHA) that examines unequal growth in percutaneous coronary intervention (PCI) centers relative to population and heart attack prevalence across the United States.
The traditional view is that hepatocyte necrosis is the main feature of fulminant hepatic failure, but increasing evidence implicates a dominant role for hepatocyte apoptosis in this pathogenesis.
The ratio of CD4 to CD8 T cells in the blood-a marker of immune system health and associated with mortality risk in the general population-is an independent predictor of coronary heart disease in HIV-infected patients, according to a new study published in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
› Verified 4 days ago
Dr. Cristina Melisa Ramos Malave, MD General Practice Medicare: Medicare Enrolled Practice Location: A2 Calle Dr Troyer, Aibonito, PR 00705 Phone: 787-735-8001 Fax: 787-954-8036 | |
Valeria Marie Gonzalez-oliveras, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 176 Calle Jose C Vazquez, Bo. Caonillas, Aibonito, PR 00705 Phone: 787-735-8001 | |
Dr. Jorge V Colon Martinez, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Calle Jose C Vazquez Interior, Bo Caonilla, Aibonito, PR 00705 Phone: 787-975-4966 | |
Dr. Winda Mar Saez Figueroa, MD General Practice Medicare: Medicare Enrolled Practice Location: Llanos Carretera Carr 725, Aibonito, PR 00705 Phone: 939-332-1269 | |
Dr. Hernando Jarier Marin Ortiz, MD General Practice Medicare: Medicare Enrolled Practice Location: Carretera Pr 726, Calle Jose C. Vazquez Km 0.2, Aibonito, PR 00705 Phone: 787-735-8001 | |
Dr. Felipe N De Jesus, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: Rius Rivera # 9, Aibonito, PR 00705 Phone: 787-735-2120 | |
Francisco Beltran, M. D. General Practice Medicare: Medicare Enrolled Practice Location: 203 Calle Julio Cintron, Aibonito, PR 00705 Phone: 787-991-3222 Fax: 787-735-4152 |